Published in Gastroenterology on June 01, 1991
The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives | NCT03291743
Fertility and pregnancy in the patient with inflammatory bowel disease. Gut (2006) 1.77
Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of Belgium. Gut (1994) 1.57
Family and twin studies in inflammatory bowel disease. World J Gastroenterol (2006) 1.54
Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut (1999) 1.09
Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. World J Gastroenterol (1998) 0.98
Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain? Gut Pathog (2010) 0.94
Campylobacter concisus and inflammatory bowel disease. World J Gastroenterol (2014) 0.93
The history of genetics in inflammatory bowel disease. Ann Gastroenterol (2014) 0.92
Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol (2015) 0.83
Ulcerative colitis in a husband and wife. Gut (1994) 0.81
Optimizing the Care and Health of Women with Inflammatory Bowel Disease. Gastroenterol Res Pract (2015) 0.81
Management of Eosinophilic Esophagitis During Pregnancy. Dig Dis Sci (2016) 0.81
IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease Patients. J Crohns Colitis (2015) 0.79
Antinuclear autoantibodies in patients with inflammatory bowel disease. High prevalence in first-degree relatives. Dig Dis Sci (1997) 0.78
Inflammatory Bowel Disease During Pregnancy. Curr Treat Options Gastroenterol (2003) 0.76
Development of Crohn's disease in husband and wife: the role of major psychological stress. Ann Gastroenterol (2014) 0.75
The study of gastric mucosa for possible bacterial causative agent of Crohn's disease. Iran J Med Sci (2012) 0.75
Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management. World J Gastrointest Pharmacol Ther (2015) 0.75
Host-microbiome interaction in Crohn's disease: A familiar or familial issue? World J Gastrointest Pathophysiol (2015) 0.75
Treatment of pregnant women with a diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther (2016) 0.75
Effects of Immunomodulators and Biologic Agents on Sexual Health in Patients With Inflammatory Bowel Disease. Ochsner J (2017) 0.75
Acute and chronic effects of different bile acids on indomethacin-induced intestinal inflammation. Inflammation (1997) 0.75
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med (1994) 6.05
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med (1980) 3.01
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology (1999) 2.25
Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet (1990) 2.13
The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol (1996) 1.83
Summary of a workshop on clindamycin colitis. J Infect Dis (1976) 1.78
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen. J Clin Gastroenterol (1990) 1.40
Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology (2001) 1.39
Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol (1997) 1.36
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33
Medical decompression of toxic megacolon by "rolling". A new technique of decompression with favorable long-term follow-up. J Clin Gastroenterol (1988) 1.30
Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18
Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17
Cerebrovascular occlusions in relatively young patients with regional enteritis. JAMA (1971) 1.12
Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci (1985) 1.05
Infliximab therapy for ulcerative colitis: many unanswered questions. Am J Gastroenterol (2001) 1.04
A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at the Mount Sinai Hospital. Mt Sinai J Med (1996) 1.02
Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis (2001) 1.02
Malabsorption and metastatic melanoma. Mt Sinai J Med (1973) 1.01
Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med (2001) 1.01
Gastric fistulas in Crohn's disease. Report of cases. Dis Colon Rectum (1989) 0.93
Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology (1986) 0.91
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy. Aliment Pharmacol Ther (2010) 0.90
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment Pharmacol Ther (2003) 0.87
Alterations in serum immunoglobulins after resection for ulcerative and granulomatous disease of the intestine. Gut (1972) 0.87
Inflammatory bowel disease related osteonecrosis: report of a large series with a review of the literature. Aliment Pharmacol Ther (2005) 0.86
Granulomatous colitis in association with diverticula. N Engl J Med (1970) 0.85
Ciprofloxacin as a treatment for ulcerative colitis-not yet. Gastroenterology (1998) 0.83
Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Scand J Gastroenterol Suppl (1988) 0.81
Crohn's disease of the duodenum associated with pancreatitis: a case report and review of the literature. Mt Sinai J Med (1987) 0.81
Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease. J Clin Gastroenterol (1984) 0.80
The prevention of Crohn's disease after surgery: metronidazole is a small but continuous medical advancement. Gastroenterology (1995) 0.79
Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther (2003) 0.79
Islet cell tumor presenting as massive upper gastrointestinal bleeding in pregnancy. Am J Gastroenterol (1988) 0.79
The modern medical management of acute, severe ulcerative colitis. Eur J Gastroenterol Hepatol (1997) 0.79
Cyclosporine and other immunosuppressive agents: current and future role in the treatment of inflammatory bowel disease. Am J Gastroenterol (1993) 0.79
Immunotherapy in inflammatory bowel disease. Med Clin North Am (1978) 0.78
Extraintestinal manifestations in patients with diverticulitis. Ann Intern Med (1988) 0.78
Maintenance oral sulfasalazine prolongs remission in ulcerative proctitis and proctosigmoiditis. Am J Gastroenterol (1991) 0.77
Refractory pouchitis: does it reflect underlying Crohn's disease? Gut (1993) 0.77
Pineal gland: influence on gonads of male rats treated with androgen 3 days after birth. Science (1968) 0.77
Withdrawal of corticosteroids in inflammatory bowel disease patients after dependency periods ranging from 2 to 45 years: a proposed method. Aliment Pharmacol Ther (2009) 0.76
Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial. Gastroenterology (1981) 0.76
Neutropenia is not required for clinical remission during azathioprine therapy in inflammatory bowel disease. Eur J Gastroenterol Hepatol (2001) 0.75
Pharmaceutical promotion and physician requests to hospital formularies. JAMA (1994) 0.75
Methotrexate for Crohn's disease. N Engl J Med (1995) 0.75
The use of 6-mercaptopurine in adolescents with Crohn's disease. Gastroenterology (1991) 0.75
The knee-elbow position relieves distension. Gut (1994) 0.75
Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents. Gastroenterology (2000) 0.75
Radiology Versus Colonoscopy in Evaluation of Colonic IBD. Inflamm Bowel Dis (1995) 0.75
What is the better surgical technique in ileal pouch-anal anastomosis? Inflamm Bowel Dis (1996) 0.75
Antibiotics are/are not effective therapy for Crohn's disease. Inflamm Bowel Dis (1997) 0.75
Matching prescription drugs and consumers. The benefits of direct advertising. N Engl J Med (1985) 0.75
Challenges in IBD Research: The Clinical Research Agenda. Inflamm Bowel Dis (1996) 0.75
Spontaneous umbilical fistula in granulomatous (Crohn's) disease of the bowel. Gastroenterology (1971) 0.75
Plugs for drugs. Regulation (1987) 0.75
Cerebrovascular occlusions in young patients with regional enteritis. Trans Am Neurol Assoc (1970) 0.75
What is the best initial treatment and maintenance therapy for distal ulcerative colitis? Inflamm Bowel Dis (1996) 0.75
What Is the Correct Sequence for Treatment of Pediatric IBD-Nutrition or Immunosuppression and/or Steroids? Inflamm Bowel Dis (1997) 0.75
Medical management of inflammatory bowel disease. DICP (1989) 0.75
The appendix and the colon: just how intimate is their relationship? Inflamm Bowel Dis (1996) 0.75
Is there any value in using cyclosporine in the treatment of Crohn's disease-to use or not to use? Inflamm Bowel Dis (1995) 0.75
Pineal, neural and photic control of reproductive organ size in early androgen-treated male rats. Neuroendocrinology (1968) 0.75
Ileal pouch-anal anastomosis for ulcerative colitis-yes, no, or maybe? Inflamm Bowel Dis (1997) 0.75
Pineal-induced ovarian atrophy in rats treated neonatally with testosterone. Life Sci (1968) 0.75
Is medical prophylaxis indicated for the prevention of recurrence of Crohn's disease after surgery? Inflamm Bowel Dis (1995) 0.75
Is the prolonged use of low-dose steroids safe for Crohn's disease? Inflamm Bowel Dis (1997) 0.75
The roentgenographic features of ureteral obstruction secondary to granulomatous disease of the bowel. Clin Radiol (1971) 0.75
Sarcoidosis among the Chinese and a review of the worldwide epidemiology of sarcoidosis. Am Rev Respir Dis (1967) 0.75
Extraintestinal manifestations. Mt Sinai J Med (1983) 0.75